QUEST DIAGNOSTICS INC (DGX) — SEC Filings

Latest SEC filings for QUEST DIAGNOSTICS INC (DGX), explained in plain English.

Sentiment Overview: 1 bullish, 26 neutral

Recent Filings (27)

• Quest Diagnostics Q3 Revenue Jumps 13.2%, Net Income Up 8.4% — 10-Q · 2025-10-21T00:00:00.000Z [bullish] Risk: medium
  Quest Diagnostics Inc. (DGX) reported robust financial performance for the three and nine months ended September 30, 2025. Net revenues for the three months inc
• 10-Q Filing — 10-Q · 2025-07-23T00:00:00.000Z [neutral]
• Quest Diagnostics Files 8-K on Financials — 8-K · 2025-07-22T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on July 22, 2025, reporting on its results of operations and financial condition. The filing also includes financial stateme
• Quest Diagnostics Reports on Shareholder Vote Matters — 8-K · 2025-05-22T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on May 22, 2025, reporting on matters submitted to a vote of security holders as of May 15, 2025. The filing indicates a sub
• Quest Diagnostics Q1 2025 10-Q Filed — 10-Q · 2025-04-23T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed its 10-Q for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025, comparing it to th
• Quest Diagnostics Files 8-K on Financials — 8-K · 2025-04-22T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on April 22, 2025, reporting on its results of operations and financial condition, as well as filing financial statements an
• Quest Diagnostics Files Definitive Proxy Materials — DEFA14A · 2025-04-11T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Incorporated filed a Definitive Additional Materials proxy statement on April 11, 2025. This filing is related to their annual meeting and lik
• Quest Diagnostics Proxy Statement Filed — DEF 14A · 2025-04-04T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed its definitive proxy statement on April 4, 2025, for its annual meeting on May 15, 2025. The filing outlines the company's governan
• Quest Diagnostics Files 8-K for Reg FD and Exhibits — 8-K · 2025-03-19T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Incorporated filed an 8-K on March 19, 2025, to report information under Regulation FD and to file financial statements and exhibits. The fili
• Quest Diagnostics Files 2024 Annual Report — 10-K · 2025-02-20T00:00:00.000Z [neutral] Risk: medium
  Quest Diagnostics Inc. filed its 2024 10-K on February 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Corning
• Quest Diagnostics Files 8-K on Financials and Events — 8-K · 2025-01-30T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on January 30, 2025, reporting on its results of operations and financial condition, as well as other events. The filing als
• Quest Diagnostics Files Q3 2024 10-Q — 10-Q · 2024-10-23T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed its 10-Q for the period ending September 30, 2024. The filing provides financial details for the third quarter and the first nine m
• Quest Diagnostics Files 8-K on Financials — 8-K · 2024-10-22T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on October 22, 2024, reporting on its results of operations and financial condition, as well as filing financial statements
• Quest Diagnostics Files 8-K — 8-K · 2024-08-29T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on August 29, 2024, reporting an event that occurred on August 23, 2024. The filing is related to financial statements and e
• Quest Diagnostics Enters Material Definitive Agreement — 8-K · 2024-08-19T00:00:00.000Z [neutral] Risk: medium
  Quest Diagnostics Incorporated announced on August 14, 2024, that it entered into a material definitive agreement. The company also reported amendments to its a
• 10-Q Filing — 10-Q · 2024-07-24T00:00:00.000Z [neutral]
• Quest Diagnostics Files 8-K on Financials — 8-K · 2024-07-23T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on July 23, 2024, to report on its results of operations and financial condition, and to file financial statements and exhib
• Quest Diagnostics Enters Material Definitive Agreement — 8-K · 2024-07-03T00:00:00.000Z [neutral] Risk: low
  On July 2, 2024, Quest Diagnostics Incorporated entered into a Material Definitive Agreement. The filing also includes information regarding Regulation FD Discl
• Quest Diagnostics Files 8-K with Corporate Updates — 8-K · 2024-05-21T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on May 21, 2024, reporting events that occurred on May 16, 2024. The filing indicates changes to the company's articles of i
• Quest Diagnostics Q1 2024 10-Q Filed — 10-Q · 2024-04-24T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed its 10-Q for the period ending March 31, 2024. The filing details the company's financial performance and position as of that date.
• Quest Diagnostics Files 8-K on Financials — 8-K · 2024-04-23T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed an 8-K on April 23, 2024, to report on its results of operations and financial condition, and to file financial statements and exhi
• Quest Diagnostics Files 2024 Proxy Statement — DEF 14A · 2024-04-05T00:00:00.000Z [neutral] Risk: low
  Quest Diagnostics Inc. filed its definitive proxy statement (DEF 14A) on April 5, 2024, for its annual meeting on May 16, 2024. The filing outlines the company'
• Quest Diagnostics Files 2023 10-K — 10-K · 2024-02-22T00:00:00.000Z [neutral] Risk: medium
  Quest Diagnostics Inc. filed its 10-K on February 22, 2024, for the fiscal year ended December 31, 2023. The filing includes financial data and corporate inform
• Vanguard Amends Quest Diagnostics Stake, Remains Passive Investor — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral] Risk: low
  The Vanguard Group, a major investment firm, filed an updated SC 13G/A on February 13, 2024, indicating its ownership of Quest Diagnostics Inc. common stock as
• Quest Diagnostics Files 8-K on Financial Results & Other Events — 8-K · 2024-02-01T00:00:00.000Z [neutral]
  Quest Diagnostics Inc. filed an 8-K on February 1, 2024, to report on its 'Results of Operations and Financial Condition' and 'Other Events.' This filing indica
• State Street Corp. Maintains Passive Stake in Quest Diagnostics — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 25, 2024, indicating its ownership of Quest Diagnostics Inc.
• BlackRock Amends Quest Diagnostics Stake as of Dec 31, 2023 — SC 13G/A · 2024-01-24T00:00:00.000Z [neutral]
  BlackRock Inc. has updated its ownership stake in Quest Diagnostics Inc. (NYSE: DGX) as of December 31, 2023, filing an Amendment No. 15 to its Schedule 13G. Th